drugset / Trial / NCT03827122
Botulinum Toxin A Injectable Solution in the Management of Bruxism: A Clinical Trial Study
NaSingle-groupOpen-labelTreatment
Summary
A Clinical Trial Study to investigate the potential performance of BTXA on masseter muscle on patient with nocturnal bruxism and to check the pain scale and share this clinical experience.
Timeline
- Start
- 2018-11-13
- Primary completion
- 2019-11-11
- Completion
- 2019-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | 20 iu | Intramuscular |